Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failure

Hypertension

Volumn 33, Issue 2, 1999, Pages 671-675

  Grassi, Guido ^a,b   Spaziani, Domenico ^c   Seravalle, Gino ^d   Bertinieri, Giovanni ^b   Dell'Oro, Raffaella ^a   Cuspidi, Cesare ^b   Mancia, Giuseppe ^a,b,d  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Ospedale di Legnano   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Autonomic; Baroreceptors; Calcium antagonists heart failure; Nervous system; Sympathetic

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; RENIN;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE; VASODILATATION;

EID: 0033030487     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.2.671     Document Type: Article

References (31)

1. Tan LB, Murray RG, Littler WA. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. Br Heart J. 1987;58:122-128.
2. Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH. A prospective, randomized, double blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990;82:1954-1961.
3. Goldstein RE, Bocuzzi SJ, Cruess D, Nattel S, for the Adverse Experience Committee and the Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postin-farction patients with early reduction in ejection fraction. Circulation. 1991;83:52-60.
4. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, De Mets DL, for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe congestive heart failure. N Engl J Med. 1996;335:1107-1114.
5. Cohn J, Ziesche S, Smith R, Anand R, Dunkman B, Loeb H, Cintron G, Boden W, Baruch L, Rochin P, Loss L, for the Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Circulation. 1997;96:856-863.
6. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
7. Packer M. Treatment of chronic heart failure. Lancet. 1992;340:92-95.
8. Frolich ED, McLoughlin HJ, Losek CJ, Ketelhut R, Messerli FM. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Am J Cardiol. 1991;68:1346-1350.
9. Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1995: 2815-2825.
10. Barjon JN, Rouleau JL, Bichet D, Juneati C, De Champlain J. Chronic, renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardiol. 1987;9: 622-630.
11. Elkayam U, Shotan A, Mehra A, Ostrzega E. Calcium channel blockers in heart failure. J Am Coll Cardiol. 1993;22(suppl A):139A-144A.
12. Kassis E, Amtorp O. Long-term clinical, hemodynamic, angiographic and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol. 1990;15: 347-352.
13. Masking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
14. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206-3211.
15. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in congestive heart failure. Circulation. 1997;96:1173-1179.
16. Mancia G, Grassi G, Ferrari AU. Reflex control of the circulation. In: Zanchetti A, Mancia G, eds. Handbook of Hypertension. Amsterdam, Netherlands: Elsevier; 1997;17:568-601.
17. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989;13:647-655.
18. Hijemdahl P, Daleskog H, Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979;25: 131-138.
19. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2:1079-1092.
20. 125-labeled ligand: comparison of three methods. J Clin Endocrinol Metab. 1978;46: 105-113.
21. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity from peripheral nerves. Physiol Rev. 1979;52:919-957.
22. Grassi G, Bolla G, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci. 1997;92: 285-289.
23. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation. 1989;80:65-77.
24. Krum H, Bigger JT, Goldsmith RL, Packer M. Effect of long-term digoxin therapy on autonomic function in patients with congestive heart failure. J Am Coll Cardiol. 1995;25:289-295.
25. Kaye DM, Jennings GL, Dart AM, Esler MD. Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. J Am Coll Cardiol. 1998;31:583-587.
26. Goldsmith SR. Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure. Am Heart J. 1997;134:13-19.
27. Mancia G, Saino A, Grassi G. Interactions between the sympathetic nervous system and the renin-angiotensin system. In: Laragh JH, Brenner GM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1995:399-408.
28. Schobel HP, Oren RM, Roach PJ, Mark AL, Ferguson DW. Contrasting effects of digitalis and dobutamine on baroreflex sympathetic control in normal humans. Circulation. 1991;84:1118-1129.
29. Ferguson DW, Hayes DW. Nifedipine potentiates cardiopulmonary baroreflex control of sympathetic nerve activity in healthy humans. Circulation. 1989;80:285-298.
30. Grassi G, Somers VK, Renk WS, Abboud FM, Mark AL. Effects of alcohol intake on blood pressure and sympathetic nerve activity in normotensive subjects. J Hypertens. 1989;7(suppl 6):S20-S21.
31. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;(suppl A):6A-13A.